Montréal Invivo
  • Business Directory
  • Newsletters
  • Events
  • News
  • FR
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Digital health
      • Artificial Intelligence
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become Partner
  • Home
  • Business Directory
  • Newsletters
  • Events
  • News
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Digital health
      • Artificial Intelligence
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become Partner
  • FRANçAIS
Back to documents
Data sheets

Law 25 – What to expect

23 Nov 2022

Law 25 will gradually come into force over the next three years, starting on September 22, 2022.

In the attached document, you will find the measures required by the law and the solutions that Fasken can provide to help you be ready.

Law 25 - What to expect - 0,17 MB
Documents

We suggest

21 May 2025
Studies and analysis

Monitoring tool for rare diseases (2025)

Update of our monitoring tool on new therapies with an indication in a rare condition and on cell and gene therapies. In collaboration with Synergyx Conseils Inc. and KMPG. This...

08 Jul 2024

Performance du secteur des SVTS québécois en termes d’emplois : Une comparaison nord-américaine

29 Mar 2012
Studies and analysis

Montréal Métro : Excellence en recherche sur le cancer

Depuis plus d’un demi-siècle maintenant, la recherche sur le cancer est un pôle d’excellence à Montréal. La notoriété de Montréal dans ce domaine résulte d’investi...

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters

I want to subscribe
Montréal Invivo
  • Press releases
  • Newsletters
  • Contact us
  • Privacy policy
514 987-9377
info@montreal-invivo.com
3650 rue Saint-Urbain, bureau 711, Montréal (Québec), H2X 2P2
All rights reserved 2026 Montréal Invivo Creation and Web Design PAR Design
×
facebook twitter X home map-marker map refresh clock chevron-left chevron-up chevron-right chevron-down angle-left angl-right angle-up angle-down angle-left angle-right angle-up angle-down fax phone book search envelope-o lock print play book calendar user share2 linkedin cloud-download youtube-play spinner calendar doc pdf svg